• Educational resources
  • Events
  • Expert Panel
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT
  • Contact us

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ItalyChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Bullous pemphigoid
  • Chronic pruritus of unknown origin
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Gastroenterology: 
  • Eosinophilic esophagitis
Pulmonology: 
  • Asthma
  • Chronic obstructive pulmonary disease
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
UEGW 2024 | WHAT Can Be Used to Monitor Treatment Response in EoE and WHEN?
Gastroenterology
11 min
expert video

UEGW 2024 | WHAT Can Be Used to Monitor Treatment Response in EoE and WHEN?

UEGW 2024 | WHY Is Long-Term Management of EoE Important?
Gastroenterology
10 min
expert video

UEGW 2024 | WHY Is Long-Term Management of EoE Important?

Pathophysiology of Blister Formation in Bullous Pemphigoid
Dermatology
2 min
expert video

Pathophysiology of Blister Formation in Bullous Pemphigoid

Factors Contributing to Diagnostic Delays in Bullous Pemphigoid
Dermatology
2 min
expert video

Factors Contributing to Diagnostic Delays in Bullous Pemphigoid

Type 2 Inflammation in AD Manifestations in Skin and Body
Dermatology
6 min
expert video

Type 2 Inflammation in AD Manifestations in Skin and Body

Etiology and Diagnosis of Bullous Pemphigoid
Dermatology
2 min
expert video

Etiology and Diagnosis of Bullous Pemphigoid

How Can FeNO Measurement Improve Severe Asthma Management?
Pulmonology
7 min
expert video

How Can FeNO Measurement Improve Severe Asthma Management?

Bullous Pemphigoid Mechanism of Disease Video
Dermatology
3 min
videoanimation

Bullous Pemphigoid Mechanism of Disease Video

Diagnosis of Bullous Pemphigoid Interactive Patient Case
Dermatology
10 min
interactivity

Diagnosis of Bullous Pemphigoid Interactive Patient Case

Explore the clinical presentations of bullous pemphigoid (BP), the steps for diagnosis, and the burden of disease.
Dermatology
10 min
Infographic

Bullous Pemphigoid (BP): Don't Miss the Diagnosis

What We Know About Bullous Pemphigoid (BP): Challenges of the Various Clinical Manifestations, Diagnosis, and Burden for Patients and Caregiver
Dermatology
10 min
expert video

What We Know About Bullous Pemphigoid (BP): Challenges of the Various Clinical Manifestations, Diagnosis, and Burden for Patients and Caregivers

Mechanisms of Disease: Autoimmunity and Role of Type 2 Inflammation in BP
Dermatology
15 min
expert video

Mechanisms of Disease: Autoimmunity and Role of Type 2 Inflammation in Bullous Pemphigoid (BP)

    1
    ...
    131415
    ...
    25